Provided by Tiger Trade Technology Pte. Ltd.

Amphastar Pharmaceuticals

21.01
+0.78003.86%
Post-market: 21.170.1600+0.76%17:38 EST
Volume:1.26M
Turnover:25.84M
Market Cap:953.23M
PE:10.35
High:21.14
Open:20.30
Low:19.95
Close:20.23
52wk High:31.26
52wk Low:19.83
Shares:45.37M
Float Shares:34.22M
Volume Ratio:1.51
T/O Rate:3.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.03
EPS(LYR):2.03
ROE:12.90%
ROA:6.37%
PB:1.21
PE(LYR):10.35

Loading ...

Amphastar Pharmaceuticals Director Richard K. Prins Reports Disposal of Common Shares

Reuters
·
Nov 26, 2025

Amphastar Pharmaceuticals Executives to Join Analyst-Moderated Fireside Chat at Piper Sandler Healthcare Conference

Reuters
·
Nov 24, 2025

Amphastar Pharmaceuticals reports Q2 net revenues of $174.4 million and net income of $31.0 million

Reuters
·
Nov 21, 2025

Director Floyd F. Petersen Reports Disposal of Amphastar Pharmaceuticals Common Shares

Reuters
·
Nov 18, 2025

Assessing Amphastar Pharmaceuticals (AMPH) Valuation After Recent Share Price Surge

Simply Wall St.
·
Nov 14, 2025

Amphastar Pharmaceuticals to Present at Jefferies Global Healthcare Conference

Reuters
·
Nov 12, 2025

Amphastar Pharmaceuticals’ Resilient Q3 2025 Earnings Call

TIPRANKS
·
Nov 11, 2025

Amphastar Pharmaceuticals Is Maintained at Buy by Needham

Dow Jones
·
Nov 07, 2025

Amphastar Pharmaceuticals Q3 revenue beats estimates

Reuters
·
Nov 07, 2025

Amphastar Pharma Q3 Adj. EPS $0.93 Beats $0.85 Estimate, Sales $191.840M Beat $184.728M Estimate

Benzinga
·
Nov 07, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 06, 2025

Amphastar Director Floyd F. Petersen Reports Sale of Common Shares

Reuters
·
Nov 06, 2025

Should Amphastar’s (AMPH) Exclusive 10-Year BAQSIMI Deal in Greater China Prompt Investor Action?

Simply Wall St.
·
Oct 26, 2025

Amphastar Pharmaceuticals Inc - on Oct 21, Co's Unit and Chengong Enter Distribution Agreement - SEC Filing

THOMSON REUTERS
·
Oct 25, 2025

Amphastar Pharmaceuticals Inc - Chengong Appointed Exclusive Distributor for Baqsimi in Greater China - SEC Filing

THOMSON REUTERS
·
Oct 25, 2025

Amphastar Pharmaceuticals Inc - Agreement Term Is 10 Years With Extension Negotiations Possible - SEC Filing

THOMSON REUTERS
·
Oct 25, 2025

Amphastar Pharmaceuticals Appoints Chengong as Exclusive Distributor for BAQSIMI in Greater China

Reuters
·
Oct 25, 2025

Amphastar Pharmaceuticals: Strategic Shift and Growth Catalysts Justify Buy Rating with $36 Target

TIPRANKS
·
Oct 22, 2025

Can Amphastar Pharmaceuticals (AMPH) Navigate Heightened Trade Tensions to Protect Its Supply Chain Advantage?

Simply Wall St.
·
Oct 13, 2025

Ionis, Jazz Named Top Picks as US Biopharma Heads Into Steady Q3, BofA Says

MT Newswires Live
·
Oct 09, 2025